back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-04 10:27 Tx date 2026-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+380,000 vol |
2,251,500 | |
| Filed 2026-04-17 17:18 Tx date 2026-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Deferred Share Units
56 - Grant of rights
|
+10,095 vol |
49,189 | |
| Filed 2026-04-17 17:18 Tx date 2025-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Deferred Share Units
56 - Grant of rights
|
+15,917 vol |
39,094 | |
| Filed 2026-04-17 17:17 Tx date 2024-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Deferred Share Units
56 - Grant of rights
|
+21,428 vol |
23,177 | |
| Filed 2026-04-17 16:18 Tx date 2020-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,000 vol |
4,729,500 | |
| Filed 2026-04-17 16:17 Tx date 2018-04-17 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+33,500 vol |
4,353,500 | |
| Filed 2026-04-17 16:16 Tx date 2022-11-16 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$24,200
+20,000 vol $1.21 each |
54,055 | |
| Filed 2025-06-03 15:33 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
1,782,000 | |
| Filed 2024-06-18 15:46 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,182,000 | |
| Filed 2023-06-26 12:39 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,997
+12,787 vol $3.91 each |
46,842 | |
| Filed 2023-06-05 16:57 Tx date 2023-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+181,000 vol |
882,000 | |
| Filed 2022-02-09 16:51 Tx date 2022-02-09 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
99 - Correction of information
|
-4,104,000 vol |
701,000 | |
| Filed 2022-02-09 16:49 Tx date 2021-07-28 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
+175,000 vol |
4,815,000 | |
| Filed 2022-02-09 16:46 Tx date 2021-10-06 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-10,000 vol |
4,805,000 | |
| Filed 2022-02-09 16:43 Tx date 2022-02-09 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-438,045 vol |
34,055 | |
| Filed 2022-02-09 16:40 Tx date 2021-08-16 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,700
+5,000 vol $3.14 each |
472,100 | |
| Filed 2022-02-09 16:38 Tx date 2020-03-29 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-41,000 vol |
0 | |
| Filed 2022-02-09 16:36 Tx date 2022-02-09 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Deferred Share Units
99 - Correction of information
|
-33,236 vol |
1,749 | |
| Filed 2020-06-02 18:13 Tx date 2020-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,000 vol |
4,640,000 | |
| Filed 2019-08-19 15:16 Tx date 2019-08-16 |
$DMA
DiaMedica Therapeutics Inc. |
Pauls, Dietrich (Rick) John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,676
+1,000 vol $2.68 each |
467,100 |